A detailed history of Journey Advisory Group, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Journey Advisory Group, LLC holds 6,967 shares of MDT stock, worth $568,089. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,967
Previous 6,967 -0.0%
Holding current value
$568,089
Previous $548,000 14.42%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$78.71 - $87.02 $7,320 - $8,092
-93 Reduced 1.32%
6,967 $548,000
Q1 2024

May 09, 2024

BUY
$82.84 - $88.09 $283,478 - $301,443
3,422 Added 94.06%
7,060 $615,000
Q4 2023

Feb 12, 2024

BUY
$69.43 - $83.43 $6,943 - $8,343
100 Added 2.83%
3,638 $299,000
Q3 2023

Nov 15, 2023

BUY
$78.22 - $90.4 $65,704 - $75,936
840 Added 31.13%
3,538 $277,000
Q1 2023

May 04, 2023

SELL
$76.72 - $87.58 $55,852 - $63,758
-728 Reduced 21.25%
2,698 $217,000
Q4 2022

Feb 07, 2023

BUY
$76.18 - $87.74 $7,618 - $8,774
100 Added 3.01%
3,426 $266,000
Q3 2022

Nov 09, 2022

SELL
$80.75 - $95.31 $105,540 - $124,570
-1,307 Reduced 28.21%
3,326 $269,000
Q2 2022

Aug 02, 2022

BUY
$87.4 - $113.09 $201,719 - $261,011
2,308 Added 99.27%
4,633 $431,000
Q1 2022

May 13, 2022

BUY
$100.58 - $112.38 $233,848 - $261,283
2,325 New
2,325 $258,000
Q4 2021

Feb 11, 2022

SELL
$99.53 - $127.75 $200,652 - $257,544
-2,016 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$122.75 - $135.17 $3,437 - $3,784
28 Added 1.41%
2,016 $253,000
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $18,910 - $21,040
160 Added 8.75%
1,988 $247,000
Q1 2021

May 11, 2021

SELL
$111.18 - $119.74 $2,779 - $2,993
-25 Reduced 1.35%
1,828 $216,000
Q4 2020

Jan 19, 2021

BUY
$100.57 - $117.14 $186,356 - $217,060
1,853 New
1,853 $217,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.